title: Refractory Rheumatoid Arthritis and Associated Interstitial Lung Disease: Could Abatacept be the Answer?
authors.affiliation: School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge University, Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, UK, wy228@cam.ac.uk School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge University, Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, UK; and Rheumatology Clinical Research Unit, Addenbrooke's Hospital, Cambridge University, Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, UK.
authors.forename: Weiyu
authors.initials: W
authors.lastname: Ye
authors.forename: Maeve C
authors.initials: MC
authors.lastname: Fifield
authors.forename: Andrew J K
authors.initials: AJ
authors.lastname: Östör
mesh_terms: D000069594:Abatacept / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D017563:Lung Diseases, Interstitial / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008297:Male; D054539:Medication Therapy Management; D008875:Middle Aged; D012129:Respiratory Function Tests / Q000379:methods; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D000069594:Abatacept